A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis
Clinical trial NCT03000608 · COMPLETED
Trial details
- NCT number
- NCT03000608
- Sponsor
- Santalis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2017-12-13
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.